Congo, Democratic Republic of the vs Mali: The number of people with susceptibility test result for rifampicin
Congo, Democratic Republic of the
22.3
in 2021
Mali
26.76
in 2021
Congo, Democratic Republic of the rank
136th
Mali rank
134th
The number of people with susceptibility test result for rifampicin over time
- Congo, Democratic Republic of the
- Mali
How they compare
Mali currently reports 26.76 against 22.3 in Congo, Democratic Republic of the, a difference of 4.46.
That makes Mali's figure about 1.2 times Congo, Democratic Republic of the's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Mali ahead.
Congo, Democratic Republic of the ranks 136th and Mali ranks 134th of 146 countries.
Across the 2 decades both report, Congo, Democratic Republic of the averaged higher in 1 and Mali in 1.
Head to head by decade
| Decade | Congo, Democratic Republic of the | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4.66 | 3.3 | 1.35 | Congo, Democratic Republic of the |
| 2020s | 15.68 | 40.18 | 24.5 | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Congo, Democratic Republic of the or Mali?
- Mali, at 26.76 against 22.3 in Congo, Democratic Republic of the as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Congo, Democratic Republic of the and Mali?
- 4.46, with Mali ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Mali?
- 5 years are reported by both, from 2017 to 2021.
- How do Congo, Democratic Republic of the and Mali rank globally for the number of people with susceptibility test result for rifampicin?
- Congo, Democratic Republic of the ranks 136th and Mali ranks 134th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.